Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
KDMF
0
NDC API
0
EDQM
0
USP
0
JP
0
Others
0
FDA Orange Book
0
Europe
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz


1. Advocid
2. Advocin
3. Danofloxacin
1. 119478-55-6
2. Danofloxacin Mesilate
3. Danofloxacin Methanesulfonate
4. Advocid
5. Danofloxacin (mesylate)
6. Danofloxacin Mesylate [usan]
7. Advocin
8. Cp-76136-27
9. 94f3sx3lem
10. 1-cyclopropyl-6-fluoro-1,4-dihydro-7-((1s,4s)-5-methyl-2,5-diazabicyclo(2.2.1)hept-2-yl)-4-oxo-3-quinolinecarboxylic Acid, Monomethanesulfonate
11. Cp-76,136-27
12. 119478-55-6 (mesylate)
13. Danofloxacin Mesylate (usan)
14. Danofloxacin Mesylate 100 Microg/ml In Acetonitrile
15. 1-cyclopropyl-6-fluoro-7-[(1s,4s)-5-methyl-2,5-diazabicyclo[2.2.1]heptan-2-yl]-4-oxoquinoline-3-carboxylic Acid;methanesulfonic Acid
16. 3-quinolinecarboxylic Acid, 1-cyclopropyl-6-fluoro-1,4-dihydro-7-(5-methyl-2,5-diazabicyclo(2.2.1)hept-2-yl)-4-oxo-, (1s)-, Monomethanesulfonate
17. Danofloxacin Mesilate Hydrate [jan]
18. Unii-94f3sx3lem
19. Advocid (tn)
20. Cp 76,136-27
21. Danofloxacin Mesilate Hydrate
22. Schembl418388
23. Danofloxacin Monomethanesulfonate
24. Chembl2106153
25. Dtxsid30922988
26. Chebi:181474
27. 1-cyclopropyl-6-fluoro-7-((1s,4s)-5-methyl-2,5-diazabicyclo[2.2.1]heptan-2-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic Acid Compound With Methanesulfonic Acid (1:1)
28. Hy-b0501
29. Mfcd00673687
30. S3058
31. Danofloxacin Mesilate [mart.]
32. Akos015895387
33. 2,4-dimethylpyrrole-3-carboxylicacid?
34. Ccg-269267
35. 1-cyclopropyl-6-fluoro-1,4-dihydro-7-[(1s,4s)-5-methyl-2,5-diazabicyclo[2.2.1]hept-2-yl]-4-oxo-3-quinolinecarboxylic Acid Mesylate
36. As-75249
37. Danofloxacin Methanesulfonate [mi]
38. Danofloxacin Mesylate 100 Microg/ml In Water
39. C71643
40. D-0245
41. D03646
42. Danofloxacin Mesylate 100 Microg/ml In Methanol
43. 478d556
44. Q27271680
45. Danofloxacin Mesylate, Antibiotic For Culture Media Use Only
46. 1-cyclopropyl-6-fluoro-7-((1s,4s)-5-methyl-2,5-diazabicyclo[2.2.1]heptan-2-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic Acid Methanesulfonic Acid Salt
47. 1-cyclopropyl-6-fluoro-7-(5-methyl-2,5-diazabicyclo[2.2.1]heptan-2-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic Acid--methanesulfonic Acid (1/1)
48. 1-cyclopropyl-6-fluoro-7-[(1s,4s)-5-methyl-2,5-diazabicyclo[2.2.1]heptan-2-yl]-4-oxo-1,4-dihydroquinoline-3-carboxylic Acid; Methanesulfonic Acid
49. 1-cyclopropyl-6-luoro-7-[(1s,4s)-5-methyl-2,5-diazabicyclo[2.2.1]heptan-2-yl]-4-oxoquinoline-3-carboxylic Acid;methanesulonic Acid
50. 3-quinolinecarboxylic Acid, 1-cyclopropyl-6-fluoro-1,4-dihydro-7-[(1s,4s)-5-methyl-2,5-diazabicyclo[2.2.1]hept-2-yl]-4-oxo-, Methanesulfonate (1:1)
| Molecular Weight | 453.5 g/mol |
|---|---|
| Molecular Formula | C20H24FN3O6S |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 10 |
| Rotatable Bond Count | 3 |
| Exact Mass | 453.13698483 g/mol |
| Monoisotopic Mass | 453.13698483 g/mol |
| Topological Polar Surface Area | 127 Ų |
| Heavy Atom Count | 31 |
| Formal Charge | 0 |
| Complexity | 772 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 2 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
Anti-Infective Agents
Substances that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection. (See all compounds classified as Anti-Infective Agents.)
7-chloro-1-cyclopropyl-6-fluoro-1, 4-dihydro-4-oxo...
CAS Number : 86393-33-1
End Use API : Danofloxacin Mesylate
About The Company : Chengda Pharmaceutical Co., Ltd. was founded in 1999. It is located in the Hangzhou-Jiaxing-Huzhou plain, Jiashan Economic & Technological Development Zone (nat...

2-(2,4-dichloro-5-fluoro-benzoyl)-3-cyclopropylami...
CAS Number : 105392-26-5
End Use API : Danofloxacin Mesylate
About The Company : Chengda Pharmaceutical Co., Ltd. was founded in 1999. It is located in the Hangzhou-Jiaxing-Huzhou plain, Jiashan Economic & Technological Development Zone (nat...

(1s)-2-methyl-2,5-diazabicyclo[2.2.1]heptane dihyd...
CAS Number : 114086-15-6
End Use API : Danofloxacin Mesylate
About The Company : Chengda Pharmaceutical Co., Ltd. was founded in 1999. It is located in the Hangzhou-Jiaxing-Huzhou plain, Jiashan Economic & Technological Development Zone (nat...

CAS Number : 6228-73-5
End Use API : Danofloxacin Mesylate
About The Company : Shree Ganesh Remedies is established Since 1995 with an aim to manufacture, supply and export best quality of Pharmaceutical-intermediates, Bulk drugs and Speci...

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : PRESCRIPTION
Registration Country : Canada
DANOFLOXACIN (DANOFLOXACIN MESYLATE)
Brand Name : A180
Dosage Form : SOLUTION
Dosage Strength : 180MG/ML
Packaging : 100ML/250ML
Approval Date :
Application Number : 2261200
Regulatory Info : PRESCRIPTION
Registration Country : Canada

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : PRESCRIPTION
Registration Country : Canada
DANOFLOXACIN (DANOFLOXACIN MESYLATE)
Brand Name : A180
Dosage Form : SOLUTION
Dosage Strength : 180MG/ML
Packaging : 100ML/250ML
Approval Date :
Application Number : 2261200
Regulatory Info : PRESCRIPTION
Registration Country : Canada

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Related Excipient Companies
Excipients by Applications
Market Place
ABOUT THIS PAGE
41
PharmaCompass offers a list of Danofloxacin Mesylate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Danofloxacin Mesylate manufacturer or Danofloxacin Mesylate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Danofloxacin Mesylate manufacturer or Danofloxacin Mesylate supplier.
A Advocid manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Advocid, including repackagers and relabelers. The FDA regulates Advocid manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Advocid API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Advocid manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.
A Advocid supplier is an individual or a company that provides Advocid active pharmaceutical ingredient (API) or Advocid finished formulations upon request. The Advocid suppliers may include Advocid API manufacturers, exporters, distributors and traders.
click here to find a list of Advocid suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.
A Advocid DMF (Drug Master File) is a document detailing the whole manufacturing process of Advocid active pharmaceutical ingredient (API) in detail. Different forms of Advocid DMFs exist exist since differing nations have different regulations, such as Advocid USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Advocid DMF submitted to regulatory agencies in the US is known as a USDMF. Advocid USDMF includes data on Advocid's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Advocid USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Advocid suppliers with USDMF on PharmaCompass.
A Advocid written confirmation (Advocid WC) is an official document issued by a regulatory agency to a Advocid manufacturer, verifying that the manufacturing facility of a Advocid active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Advocid APIs or Advocid finished pharmaceutical products to another nation, regulatory agencies frequently require a Advocid WC (written confirmation) as part of the regulatory process.
click here to find a list of Advocid suppliers with Written Confirmation (WC) on PharmaCompass.
Advocid Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Advocid GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Advocid GMP manufacturer or Advocid GMP API supplier for your needs.
A Advocid CoA (Certificate of Analysis) is a formal document that attests to Advocid's compliance with Advocid specifications and serves as a tool for batch-level quality control.
Advocid CoA mostly includes findings from lab analyses of a specific batch. For each Advocid CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Advocid may be tested according to a variety of international standards, such as European Pharmacopoeia (Advocid EP), Advocid JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Advocid USP).